| Home > Articles > Published articles > LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model |
| Date: | 2025 |
| Abstract: | Parkinson's disease (PD) is a progressive, incurable neurodegenerative disorder characterized by the loss of neuromelanin (NM)-containing dopamine neurons (DAn) in the substantia nigra of the midbrain. Non-neuronal cells are increasingly recognized as contributors to PD. We generated human microglia-like cells (hMG) from induced pluripotent stem cells (iPSC) derived from patients with LRRK2 PD-causing mutations, gene-corrected isogenic controls, and healthy donors. While neither genotype induced neurodegeneration in healthy DAn, LRRK2 hMG become hyperreactive to LPS stimulation, exhibiting increased cytokine expression, reactive oxygen species, and phagocytosis. When exposed to NM-containing particles, but not α-synuclein fibrils, LRRK2 hMG trigger DAn degeneration, in a process that is prevented by pre-treatment with the immunomodulatory drug ivermectin. Finally, post-mortem analysis of midbrain tissue of LRRK2-PD patients show increased microglia activation around NM-containing neurons, confirming our in vitro findings. Overall, our work highlights NM-activated microglia's role in PD progression, and provides a model for testing therapeutic targets. (Figure presented. ). |
| Grants: | Agencia Estatal de Investigación PID2019-108792GB-I00 Agencia Estatal de Investigación PID2020-116339RB-I00 Agencia Estatal de Investigación PID2021-123925OB-I00 Agencia Estatal de Investigación PID2022-137963OB-I00 Agencia Estatal de Investigación PID2022-139546OB-I00 Fundació la Marató de TV3 202012-32 Fundació la Marató de TV3 202331-30 Ministerio de Economía y Competitividad RD16/0011/0024 Agència de Gestió d'Ajuts Universitaris i de Recerca 2021/SGR-974 |
| Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
| Language: | Anglès |
| Document: | Article ; recerca ; Versió publicada |
| Subject: | Dopaminergic Neurons ; Humans ; Induced Pluripotent Stem Cells ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ; Melanins ; Microglia ; Mutation ; Parkinson Disease |
| Published in: | Communications Biology, Vol. 8 Núm. 1 (december 2025) , p. 1203, ISSN 2399-3642 |
15 p, 2.8 MB |